astrazeneca hit by drug failure shares in anglo swedish drug have closed down 8 in uk trade after the failure of its iressa drug in a major clinical tria . and we ve got risks on crestor said nick turner analyst at brokers jefferie i am determined to improve our development and regulatory performance restore confidence in the company and value to shareholders said chief executive tom mckillo tarceva made by osi pharmaceuticals genentech and roche has already proved to be successful in helping prolong the life of lung cancer patient